Slip Opinion
Bankr. D.N.J.2025Background
- Invitae, a medical genetics company, faced severe liquidity stress after multiple acquisitions and large unsecured note maturities in 2024, prompting restructuring efforts and two prepetition exchanges with Deerfield (March and August 2023).
- The March Exchange converted most 2024 unsecured notes into 2028 secured notes and stock (and added $30M cash); the Committee alleges the transactions advantaged Deerfield and harmed similarly situated unsecured creditors.
- Invitae filed Chapter 11 in February 2024, entered a Transaction Support Agreement (TSA) with Deerfield at filing, and ran a sale process that produced a Labcorp transaction; Deerfield’s credit-bidding activity increased the sale price.
- The Official Committee of Unsecured Creditors moved for derivative standing to sue to avoid/recoup the March and August Exchanges and related transfers; the Bankruptcy Court denied standing after evidentiary hearings.
- The confirmed Chapter 11 Plan (Article VII.C) contained releases of debtors’ claims against Deerfield, certain directors/officers, and other released parties; the Committee appealed both the standing denial and plan confirmation.
- On limited remand the Bankruptcy Court issued a detailed supplemental opinion crediting an independent director’s investigation and professional testimony; the district court affirmed both the denial of derivative standing and confirmation with releases.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether the Committee should receive derivative standing to sue on estate claims (unjustifiability/cost-benefit) | Committee: Debtor unjustifiably refused to pursue colorable fraudulent-transfer and fiduciary-duty claims; litigation would benefit the estate. | Debtor/Deerfield: extensive prepetition review, independent investigation, material risks (safe-harbor, exculpation, insolvency disputes), and high cost/delay made declining suit justified. | Denied: Bankruptcy Court’s cost-benefit/unjustifiability analysis was reasonable and credited investigator/professional testimony; district court affirmed (abuse-of-discretion review). |
| Whether the Plan’s non-debtor releases were fair and confirmable | Committee: Releases improperly bar pursuit of potentially meritorious estate claims and are overbroad. | Debtor/Deerfield: Releases were negotiated consideration; Deerfield and management materially contributed (TSA, credit-bid, cash-collateral, sale process); releases necessary for Plan feasibility and creditor recoveries. | Affirmed: Court applied Master Mortgage factors and found identity of interest, substantial contributions, necessity to reorganization, creditor acceptance, and meaningful recoveries supported releases as fair and equitable. |
Key Cases Cited
- Cybergenics Corp. v. Chinery, 330 F.3d 548 (3d Cir.) (derivative standing doctrine for creditors’ committees; trustee/debtor duty to pursue avoidance actions)
- STN Enters. v. Continental Ins. Co., 779 F.2d 901 (2d Cir.) (test requiring colorable claim and unjustifiable refusal; court performs cost-benefit analysis)
- In re Adelphia Commc’ns Corp., 544 F.3d 420 (2d Cir.) (bankruptcy-derivative standing discussion and limits on committees’ authority)
- In re Cohn, 54 F.3d 1108 (3d Cir.) (district court appellate powers over bankruptcy court orders)
- Meridian Bank v. Alten, 958 F.2d 1226 (3d Cir.) (standards of review for mixed questions of law and fact on bankruptcy appeals)